STAAR Surgical SG&A Expenses 2012-2026 | STAA
STAAR Surgical sg&a expenses from 2012 to 2026. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
|
STAAR Surgical Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2025 | $188 |
| 2024 | $198 |
| 2023 | $180 |
| 2022 | $144 |
| 2021 | $111 |
| 2020 | $80 |
| 2019 | $75 |
| 2018 | $63 |
| 2017 | $48 |
| 2016 | $50 |
| 2015 | $43 |
| 2014 | $44 |
| 2013 | $43 |
| 2012 | $39 |
| 2011 | $34 |
|
STAAR Surgical Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2026-03-31 | $42 |
| 2025-12-31 | $48 |
| 2025-09-30 | $44 |
| 2025-06-30 | $47 |
| 2025-03-31 | $49 |
| 2024-12-31 | $43 |
| 2024-09-30 | $51 |
| 2024-06-30 | $55 |
| 2024-03-31 | $50 |
| 2023-12-31 | $39 |
| 2023-09-30 | $46 |
| 2023-06-30 | $50 |
| 2023-03-31 | $44 |
| 2022-12-31 | $39 |
| 2022-09-30 | $37 |
| 2022-06-30 | $38 |
| 2022-03-31 | $29 |
| 2021-12-31 | $29 |
| 2021-09-30 | $29 |
| 2021-06-30 | $30 |
| 2021-03-31 | $23 |
| 2020-12-31 | $21 |
| 2020-09-30 | $21 |
| 2020-06-30 | $18 |
| 2020-03-31 | $19 |
| 2019-12-31 | $19 |
| 2019-09-30 | $20 |
| 2019-06-30 | $19 |
| 2019-03-31 | $17 |
| 2018-12-31 | $16 |
| 2018-09-30 | $17 |
| 2018-06-30 | $17 |
| 2018-03-31 | $13 |
| 2017-12-31 | $13 |
| 2017-09-30 | $11 |
| 2017-06-30 | $12 |
| 2017-03-31 | $12 |
| 2016-12-31 | $10 |
| 2016-09-30 | $12 |
| 2016-06-30 | $12 |
| 2016-03-31 | $16 |
| 2015-12-31 | $11 |
| 2015-09-30 | $11 |
| 2015-06-30 | $11 |
| 2015-03-31 | $11 |
| 2014-12-31 | $10 |
| 2014-09-30 | $10 |
| 2014-06-30 | $13 |
| 2014-03-31 | $12 |
| 2013-12-31 | $12 |
| 2013-09-30 | $10 |
| 2013-06-30 | $10 |
| 2013-03-31 | $10 |
| 2012-12-31 | $11 |
| 2012-09-30 | $10 |
| 2012-06-30 | $10 |
| 2012-03-31 | $9 |
| 2011-12-31 | $9 |
| 2011-09-30 | $8 |
| 2011-06-30 | $8 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $1.309B | $0.239B |
| Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |